Bufetolol

Summary

Bufetolol is a beta-adrenoceptor antagonist.[1]

Bufetolol
Names
IUPAC name
1-(tert-Butylamino)-3-[2-(oxolan-2-ylmethoxy)phenoxy]propan-2-ol
Identifiers
  • 53684-49-4
3D model (JSmol)
  • Interactive image
ChEMBL
  • ChEMBL347830
ChemSpider
  • 2371
KEGG
  • D01504
  • 2465
UNII
  • WS1467RT9Z
  • DTXSID9057763 Edit this at Wikidata
  • InChI=1S/C18H29NO4/c1-18(2,3)19-11-14(20)12-22-16-8-4-5-9-17(16)23-13-15-7-6-10-21-15/h4-5,8-9,14-15,19-20H,6-7,10-13H2,1-3H3
    Key: AKLNLVOZXMQGSI-UHFFFAOYSA-N
  • InChI=1/C18H29NO4/c1-18(2,3)19-11-14(20)12-22-16-8-4-5-9-17(16)23-13-15-7-6-10-21-15/h4-5,8-9,14-15,19-20H,6-7,10-13H2,1-3H3
    Key: AKLNLVOZXMQGSI-UHFFFAOYAN
  • CC(C)(C)NCC(COC1=CC=CC=C1OCC2CCCO2)O
Properties
C18H29NO4
Molar mass 323.433 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

References edit

  1. ^ Sada, H; Harada, S; Ban, T (1983). "Effects of beta-adrenoceptor blocking agents of N-tertiary butyl derivatives on maximum upstroke velocity of action potential in guinea-pig papillary muscles". Naunyn-Schmiedeberg's Archives of Pharmacology. 324 (1): 50–7. doi:10.1007/bf00647838. PMID 6138715.